Add a bookmark to get started

7 January 20243 minute read

DLA Piper @ JP Morgan 2024

San Francisco, CA
January 7, 2024 – January 9, 2024


January 7, 2024

8:30 am - 10:00 am PT - What is next for biopharmaceutical policy in 2024? Focus on impact on launch and commercialization
Attendees will gain an understanding of major policy changes and federal policy debates in 2024. The focus is anticipating the impact of these policy changes on product approval, launch and revenue expectations in the US for in line and pipeline biopharmaceuticals. Topics will include: Inflation Reduction Act Implementation, Anticipated Challenges in IP, Focus on M&A across the healthcare industry and the overlay of drug pricing in all these debates.


  • Senator Richard Burr, Principal Policy Advisor, DLA Piper
  • Kirsten Axelsen, Senior Policy Advisor, DLA Piper

January 8, 2024

12:00 pm - 2:00 pm PT - The State of Life Sciences Financing Transactions: A review of 2023 and forecast for 2024
Today’s biotechnology and pharmaceutical landscape continues in a world with economic, regulatory, and now even greater geo-political uncertainty. In the face of these challenges, this industry continues to be innovative to serve patients and create opportunities. We will review life science financing transactions in 2023 and then discuss the trends that will shape the sector in 2024.

Our panelists will provide an in-depth review from the venture capital, pharma investor, and venture debt perspectives, with an overview from an experienced investment banker.


  • Emilio Ragosa, Managing Partner, Short Hills Office, DLA Piper
  • Katherine Andersen, Head of Life Science & Healthcare, HSBC Bank USA
  • Seth Warshaw, Managing Director, Cantor Fitzgerald
  • Lucian Iancovici, M.D., Principal, TPG Growth
  • Bill Burkoth, Managing Partner of Life Sciences, The Forest Road Company

January 9, 2024

12:00 pm - 2:00 pm PT - The Future of Healthcare
Investing to sustain health and advances in technology are pushing the boundaries of healthcare services and delivery, generating new benefits and ways for patients, providers, and payors to collaborate within the medical community.

Please join us for a lively lunch discussion during the JP Morgan Healthcare Conference as our panelists touch on the innovation happening in healthcare services, and the unique opportunities and obstacles that come from healthcare system transformation.


  • Joshua Kaye, Managing Partner, Miami Office; Chair, US Healthcare Sector, DLA Piper
  • Keo Shaw, Of Counsel, DLA Piper
  • Danny Tobey M.D., J.D., Partner, Chair, AI and Data Analytics, DLA Piper

5:00 pm - 8:00 pm PT - DLA Piper Reception
Noted for being the best party at JP Morgan, this evening event at the Hawthorn in Union Square is our tribute and thank you to clients, referral sources, and others who would like to continue to network or otherwise relax and have an enjoyable evening after a long day.


For more information, please contact Cheryl Freedman.